AAAAAA

   
Results: 1-25 | 26-40
Results: 1-25/40
SUPPRESSION OF DIACYLGLYCEROL LEVELS BY ANTIBODIES REACTIVE WITH THE C-ERBB-2 (HER-2 NEU) GENE-PRODUCT P185(C-ERBB-2) IN BREAST AND OVARIAN-CANCER CELL-LINES/
Authors: BOENTE MP BERCHUCK A WHITAKER RS KALEN A XU FJ CLARKEPEARSON DL BELL RM BAST RC
Citation: Mp. Boente et al., SUPPRESSION OF DIACYLGLYCEROL LEVELS BY ANTIBODIES REACTIVE WITH THE C-ERBB-2 (HER-2 NEU) GENE-PRODUCT P185(C-ERBB-2) IN BREAST AND OVARIAN-CANCER CELL-LINES/, Gynecologic oncology (Print), 70(1), 1998, pp. 49-55
COMBINATION PACLITAXEL (TAXOL(R))-CISPLATIN VS CYCLOPHOSPHAMIDE-CISPLATIN AS PRIMARY THERAPY IN PATIENTS WITH SUBOPTIMALLY DEBULKED ADVANCED OVARIAN-CANCER
Authors: HOSKINS WJ MCGUIRE WP BRADY MF KUCERA PR PARTRIDGE EE LOOK KY CLARKEPEARSON DL DAVIDSON M
Citation: Wj. Hoskins et al., COMBINATION PACLITAXEL (TAXOL(R))-CISPLATIN VS CYCLOPHOSPHAMIDE-CISPLATIN AS PRIMARY THERAPY IN PATIENTS WITH SUBOPTIMALLY DEBULKED ADVANCED OVARIAN-CANCER, International journal of gynecological cancer, 7, 1997, pp. 9-13
RANDOMIZED TRIAL OF CISPLATIN VERSUS CISPLATIN PLUS MITOLACTOL VERSUSCISPLATIN PLUS IFOSFAMIDE IN ADVANCED SQUAMOUS CARCINOMA OF THE CERVIX - A GYNECOLOGIC-ONCOLOGY-GROUP STUDY
Authors: OMURA GA BLESSING JA VACCARELLO L BERMAN ML CLARKEPEARSON DL MUTCH DG ANDERSON B
Citation: Ga. Omura et al., RANDOMIZED TRIAL OF CISPLATIN VERSUS CISPLATIN PLUS MITOLACTOL VERSUSCISPLATIN PLUS IFOSFAMIDE IN ADVANCED SQUAMOUS CARCINOMA OF THE CERVIX - A GYNECOLOGIC-ONCOLOGY-GROUP STUDY, Journal of clinical oncology, 15(1), 1997, pp. 165-171
RACIAL DISPARITY IN OVEREXPRESSION OF THE P53 TUMOR-SUPPRESSOR GENE IN STAGE-I ENDOMETRIAL CANCER
Authors: CLIFFORD SL KAMINETSKY CP CIRISANO FD DODGE R SOPER JT CLARKEPEARSON DL BERCHUCK A
Citation: Sl. Clifford et al., RACIAL DISPARITY IN OVEREXPRESSION OF THE P53 TUMOR-SUPPRESSOR GENE IN STAGE-I ENDOMETRIAL CANCER, American journal of obstetrics and gynecology, 176(6), 1997, pp. 229-232
COMPARISON OF COMBINATION THERAPY WITH PACLITAXEL TAXOL(R) AND CISPLATIN VERSUS CYCLOPHOSPHAMIDE AND CISPLATIN IN PATIENTS WITH SUBOPTIMAL STAGE-III AND STAGE-IV OVARIAN-CANCER - A GYNECOLOGIC-ONCOLOGY-GROUP STUDY
Authors: MCGUIRE WP HOSKINS WJ BRADY MF KUCERA PR PARTRIDGE EE LOOK KY CLARKEPEARSON DL DAVIDSON M
Citation: Wp. Mcguire et al., COMPARISON OF COMBINATION THERAPY WITH PACLITAXEL TAXOL(R) AND CISPLATIN VERSUS CYCLOPHOSPHAMIDE AND CISPLATIN IN PATIENTS WITH SUBOPTIMAL STAGE-III AND STAGE-IV OVARIAN-CANCER - A GYNECOLOGIC-ONCOLOGY-GROUP STUDY, International journal of gynecological cancer, 6, 1996, pp. 2-8
PHASE-III STUDY OF INTRAPERITONEAL CISPLATIN-INTRAVENOUS CYCLOPHOSPHAMIDE VERSUS INTRAVENOUS CISPLATIN-INTRAVENOUS CYCLOPHOSPHAMIDE IN PATIENTS WITH OPTIMAL DISEASE STAGE-III OVARIAN-CANCER - A SWOG-GOG-ECOG INTERGROUP STUDY
Authors: ALBERTS DS LIU PY HANNIGAN EV OTOOLE R WILLIAMS SD YOUNG JA FRANKLIN EW CLARKEPEARSON DL MALVIYA VK DUBESHTER B HOSKINS WJ ADELSON MD ALVAREZ RD OSULLIVAN J GARCIA DJ SPARKS DB QUADE J ROTHENBERG ML
Citation: Ds. Alberts et al., PHASE-III STUDY OF INTRAPERITONEAL CISPLATIN-INTRAVENOUS CYCLOPHOSPHAMIDE VERSUS INTRAVENOUS CISPLATIN-INTRAVENOUS CYCLOPHOSPHAMIDE IN PATIENTS WITH OPTIMAL DISEASE STAGE-III OVARIAN-CANCER - A SWOG-GOG-ECOG INTERGROUP STUDY, International journal of gynecological cancer, 6, 1996, pp. 28-29
CYCLOPHOSPHAMIDE AND CISPLATIN VERSUS PACLITAXEL AND CISPLATIN - A PHASE-III RANDOMIZED TRIAL IN PATIENTS WITH SUBOPTIMAL STAGE III IV OVARIAN-CANCER (FROM THE GYNECOLOGIC-ONCOLOGY-GROUP)/
Authors: MCGUIRE WP HOSKINS WJ BRADY MF KUCERA PR PARTRIDGE EE LOOK KY CLARKEPEARSON DL DAVIDSON M
Citation: Wp. Mcguire et al., CYCLOPHOSPHAMIDE AND CISPLATIN VERSUS PACLITAXEL AND CISPLATIN - A PHASE-III RANDOMIZED TRIAL IN PATIENTS WITH SUBOPTIMAL STAGE III IV OVARIAN-CANCER (FROM THE GYNECOLOGIC-ONCOLOGY-GROUP)/, Seminars in oncology, 23(5), 1996, pp. 40-47
AN ANALYSIS OF CELL-TYPE IN PATIENTS WITH SURGICALLY STAGED STAGE IB CARCINOMA OF THE CERVIX - A GYNECOLOGIC-ONCOLOGY-GROUP STUDY
Authors: LOOK KY BRUNETTO VL CLARKEPEARSON DL AVERETTE HE MAJOR FJ ALVAREZ RD HOMESLEY HD ZAINO RJ
Citation: Ky. Look et al., AN ANALYSIS OF CELL-TYPE IN PATIENTS WITH SURGICALLY STAGED STAGE IB CARCINOMA OF THE CERVIX - A GYNECOLOGIC-ONCOLOGY-GROUP STUDY, Gynecologic oncology, 63(3), 1996, pp. 304-311
METASTATIC CLEAR-CELL ECCRINE HIDRADENOCARCINOMA OF THE VULVA - SURVIVAL AFTER PRIMARY SURGICAL RESECTION
Authors: MASSAD LS BITTERMAN P CLARKEPEARSON DL
Citation: Ls. Massad et al., METASTATIC CLEAR-CELL ECCRINE HIDRADENOCARCINOMA OF THE VULVA - SURVIVAL AFTER PRIMARY SURGICAL RESECTION, Gynecologic oncology, 61(2), 1996, pp. 287-290
INTRAPERITONEAL CISPLATIN PLUS INTRAVENOUS CYCLOPHOSPHAMIDE VERSUS INTRAVENOUS CISPLATIN PLUS INTRAVENOUS CYCLOPHOSPHAMIDE FOR STAGE-III OVARIAN-CANCER
Authors: ALBERTS DS LIU PY HANNIGAN EV OTOOLE R WILLIAMS SD YOUNG JA FRANKLIN EW CLARKEPEARSON DL MALVIYA VK DUBESHTER B ADELSON MD HOSKINS WJ
Citation: Ds. Alberts et al., INTRAPERITONEAL CISPLATIN PLUS INTRAVENOUS CYCLOPHOSPHAMIDE VERSUS INTRAVENOUS CISPLATIN PLUS INTRAVENOUS CYCLOPHOSPHAMIDE FOR STAGE-III OVARIAN-CANCER, The New England journal of medicine, 335(26), 1996, pp. 1950-1955
CYCLOPHOSPHAMIDE AND CISPLATIN COMPARED WITH PACLITAXEL AND CISPLATININ PATIENTS WITH STAGE-III AND STAGE-IV OVARIAN-CANCER
Authors: MCGUIRE WP HOSKINS WJ BRADY MF KUCERA PR PARTRIDGE EE LOOK KY CLARKEPEARSON DL DAVIDSON M
Citation: Wp. Mcguire et al., CYCLOPHOSPHAMIDE AND CISPLATIN COMPARED WITH PACLITAXEL AND CISPLATININ PATIENTS WITH STAGE-III AND STAGE-IV OVARIAN-CANCER, The New England journal of medicine, 334(1), 1996, pp. 1-6
P53 OVEREXPRESSION IN ADVANCED-STAGE ENDOMETRIAL ADENOCARCINOMA
Authors: KOHLER MF CARNEY P DODGE R SOPER JT CLARKEPEARSON DL MARKS JR BERCHUCK A
Citation: Mf. Kohler et al., P53 OVEREXPRESSION IN ADVANCED-STAGE ENDOMETRIAL ADENOCARCINOMA, American journal of obstetrics and gynecology, 175(5), 1996, pp. 1246-1252
SITES OF FAILURE AND TIMES TO FAILURE IN CARCINOMA OF THE VULVA TREATED CONSERVATIVELY - A GYNECOLOGIC-ONCOLOGY-GROUP STUDY
Authors: STEHMAN FB BUNDY BN BALL H CLARKEPEARSON DL
Citation: Fb. Stehman et al., SITES OF FAILURE AND TIMES TO FAILURE IN CARCINOMA OF THE VULVA TREATED CONSERVATIVELY - A GYNECOLOGIC-ONCOLOGY-GROUP STUDY, American journal of obstetrics and gynecology, 174(4), 1996, pp. 1128-1132
GESTATIONAL TROPHOBLASTIC DISEASE METASTATIC TO THE CENTRAL-NERVOUS-SYSTEM
Authors: EVANS AC SOPER JT CLARKEPEARSON DL BERCHUCK A RODRIGUEZ GC HAMMOND CB
Citation: Ac. Evans et al., GESTATIONAL TROPHOBLASTIC DISEASE METASTATIC TO THE CENTRAL-NERVOUS-SYSTEM, Gynecologic oncology, 59(2), 1995, pp. 226-230
POSTSURGICAL SURVEILLANCE OF PATIENTS WITH FIGO STAGE I II ENDOMETRIAL ADENOCARCINOMA/
Authors: BERCHUCK A ANSPACH C EVANS AC SOPER JT RODRIGUEZ GC DODGE R ROBBOY S CLARKEPEARSON DL
Citation: A. Berchuck et al., POSTSURGICAL SURVEILLANCE OF PATIENTS WITH FIGO STAGE I II ENDOMETRIAL ADENOCARCINOMA/, Gynecologic oncology, 59(1), 1995, pp. 20-24
COMBINATIONS OF MULTIPLE SERUM MARKERS ARE SUPERIOR TO INDIVIDUAL ASSAYS FOR DISCRIMINATING MALIGNANT FROM BENIGN PELVIC MASSES
Authors: WOOLAS RP CONAWAY MR XU FJ JACOBS IJ YU YH DALY L DAVIES AP OBRIANT K BERCHUCK A SOPER JT CLARKEPEARSON DL RODRIGUEZ G ORAM DH BAST RC
Citation: Rp. Woolas et al., COMBINATIONS OF MULTIPLE SERUM MARKERS ARE SUPERIOR TO INDIVIDUAL ASSAYS FOR DISCRIMINATING MALIGNANT FROM BENIGN PELVIC MASSES, Gynecologic oncology, 59(1), 1995, pp. 111-116
ETOPOSIDE PLATIN COMBINATION THERAPY FOR CHEMOREFRACTORY GESTATIONAL TROPHOBLASTIC DISEASE
Authors: SOPER JT EVANS AC RODRIGUEZ G BERCHUCK A CLARKEPEARSON DL HAMMOND CB
Citation: Jt. Soper et al., ETOPOSIDE PLATIN COMBINATION THERAPY FOR CHEMOREFRACTORY GESTATIONAL TROPHOBLASTIC DISEASE, Gynecologic oncology, 56(3), 1995, pp. 421-424
LONG AND SHORT GRACILIS MYOCUTANEOUS FLAPS FOR VULVO-VAGINAL RECONSTRUCTION AFTER RADICAL PELVIC-SURGERY - COMPARISON OF FLAP-SPECIFIC COMPLICATIONS
Authors: SOPER JT RODRIGUEZ G BERCHUCK A CLARKEPEARSON DL
Citation: Jt. Soper et al., LONG AND SHORT GRACILIS MYOCUTANEOUS FLAPS FOR VULVO-VAGINAL RECONSTRUCTION AFTER RADICAL PELVIC-SURGERY - COMPARISON OF FLAP-SPECIFIC COMPLICATIONS, Gynecologic oncology, 56(2), 1995, pp. 271-275
CERVICAL-CARCINOMA - DETERMINATION OF RECURRENT TURNER EXTENT VERSUS RADIATION CHANGES WITH MR-IMAGING
Authors: WEBER TM SOSTMAN HD SPRITZER CE BALLARD RL MEYER GA CLARKEPEARSON DL SOPER JT
Citation: Tm. Weber et al., CERVICAL-CARCINOMA - DETERMINATION OF RECURRENT TURNER EXTENT VERSUS RADIATION CHANGES WITH MR-IMAGING, Radiology, 194(1), 1995, pp. 135-139
RELATIONSHIP BETWEEN RACE AND INTERVAL TO TREATMENT IN ENDOMETRIAL CANCER
Authors: LIU JR CONAWAY M RODRIGUEZ GC SOPER JT CLARKEPEARSON DL BERCHUCK A
Citation: Jr. Liu et al., RELATIONSHIP BETWEEN RACE AND INTERVAL TO TREATMENT IN ENDOMETRIAL CANCER, Obstetrics and gynecology, 86(4), 1995, pp. 486-490
THE SAFETY AND PHARMACOKINETICS IN ADULT SUBJECTS OF AN INTRAVENOUSLYADMINISTERED TC-99M-LABELED 17 AMINO-ACID PEPTIDE (CYT-379)
Authors: BENHAIM S KAHN D WEINER GJ MADSEN MT WAXMAN AD WILLIAMS CM CLARKEPEARSON DL COLEMAN RE MAGUIRE RT
Citation: S. Benhaim et al., THE SAFETY AND PHARMACOKINETICS IN ADULT SUBJECTS OF AN INTRAVENOUSLYADMINISTERED TC-99M-LABELED 17 AMINO-ACID PEPTIDE (CYT-379), Nuclear medicine and biology, 21(2), 1994, pp. 131-142
5-DAY METHOTREXATE FOR WOMEN WITH METASTATIC GESTATIONAL TROPHOBLASTIC DISEASE
Authors: SOPER JT CLARKEPEARSON DL BERCHUCK A RODRIGUEZ G HAMMOND CB
Citation: Jt. Soper et al., 5-DAY METHOTREXATE FOR WOMEN WITH METASTATIC GESTATIONAL TROPHOBLASTIC DISEASE, Gynecologic oncology, 54(1), 1994, pp. 76-79
THE REASSESSMENT OF OVARIAN-CANCER IN COMPLETE CLINICAL REMISSION - WHAT ARE OUR GOALS
Authors: CLARKEPEARSON DL
Citation: Dl. Clarkepearson, THE REASSESSMENT OF OVARIAN-CANCER IN COMPLETE CLINICAL REMISSION - WHAT ARE OUR GOALS, Gynecologic oncology, 52(2), 1994, pp. 151-153
OVEREXPRESSION OF P53 IS NOT A FEATURE OF BENIGN AND EARLY-STAGE BORDERLINE EPITHELIAL OVARIAN-TUMORS
Authors: BERCHUCK A KOHLER MF HOPKINS MP HUMPHREY PA ROBBOY SJ RODRIGUEZ GC SOPER JT CLARKEPEARSON DL BAST RC
Citation: A. Berchuck et al., OVEREXPRESSION OF P53 IS NOT A FEATURE OF BENIGN AND EARLY-STAGE BORDERLINE EPITHELIAL OVARIAN-TUMORS, Gynecologic oncology, 52(2), 1994, pp. 232-236
EVALUATION OF PROGNOSTIC FACTORS AND STAGING IN GESTATIONAL TROPHOBLASTIC TUMOR
Authors: SOPER JT EVANS AC CONAWAY MR CLARKEPEARSON DL BERCHUCK A HAMMOND CB
Citation: Jt. Soper et al., EVALUATION OF PROGNOSTIC FACTORS AND STAGING IN GESTATIONAL TROPHOBLASTIC TUMOR, Obstetrics and gynecology, 84(6), 1994, pp. 969-973
Risultati: 1-25 | 26-40